ESR1 and breast cancer: Motivated by the observations suggesting an efficient staining of nuclear ERα in the cultured ERα-positive breast cancer cells by the ERaptD4, we attempted to ascertain the clinical applicability of this aptamer in evaluating the ERα expression, by selective staining of ERα-positive cells, to assist in breast cancer diagnosis and grading.